![Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm2007613/asset/images/large/jm-2011-007613_0019.jpeg)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) | Journal of Medicinal Chemistry
![Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae | Hypertension Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae | Hypertension](https://www.ahajournals.org/cms/asset/9e8879bf-4a30-442f-8dee-062eca940e4f/hypertensionaha.122.19958.fig06.jpg)
Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae | Hypertension
![Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era](https://pub.mdpi-res.com/biomedicines/biomedicines-10-01927/article_deploy/html/images/biomedicines-10-01927-g001.png?1660192940)
Biomedicines | Free Full-Text | Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
![IJMS | Free Full-Text | Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy IJMS | Free Full-Text | Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy](https://www.mdpi.com/ijms/ijms-23-14181/article_deploy/html/images/ijms-23-14181-g001.png)